Roche Holding AG (LON:0TDF)

Market Cap	282.74B +48.7%
Revenue (ttm)	59.37B +1.5%
Net Income	12.07B +55.6%
EPS	n/a
Shares Out	n/a
PE Ratio	23.43
Forward PE	18.38
Dividend	0.67 (1.22%)
Ex-Dividend Date	Mar 28, 2025

Volume	102,582
Average Volume	123,117
Open	57.06
Previous Close	57.22
Day's Range	56.65 - 57.12
52-Week Range	35.14 - 57.24
Beta	0.17
RSI	68.02
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0TDF

Financial Performance

In 2025, Roche Holding AG's revenue was 63.36 billion, an increase of 1.54% compared to the previous year's 62.40 billion. Earnings were 12.88 billion, an increase of 55.61%.

Financial numbers in CHF